Cholesterol Lowering Medications are Used to Treat Danes
More than 600,000 Danes are being treated with cholesterol lowering medicine. 98 per cent of them are treated with statins, which curb the body's own
More than 600,000 Danes are being treated with cholesterol lowering medicine. 98 per cent of them are treated with statins, which curb the body's own
Common heart medications, like beta blockers, could have side effects including triggering depression in heart attack patients.
Recent research has demonstrated that a widely prescribed hypertension medication, medlinkamlodipine/medlink, is safe for patients. This finding contradicts
Truvada, used as pre-exposure prophylaxis to prevent HIV infection (PrEP), can reveal patterns of medication-taking behavior that may put persons at risk of prophylactic failure.
Patients Presenting Medication Lists Reduce the Risk of Error During Hospital Admission
Recent data reveals that the incidence of seizures in children caused by ingesting medications or illegal substances has doubled in the US from 2009 to 2023.
These drugs could have beneficial population-wide effects in areas at risk for malaria and Zika, according to modeling study
The approved medication, therapeutically equivalent to Bausch Health’s Cardizem CD Extended-Release Capsules, is used to treat hypertension and manage chronic stable angina
Medication errors are among the most common medical errors, harming at least 1.5 million people every year, says a new report from the Institute of Medicine of the National Academies.
Medications to Treat Opioid Addiction Are Effective and Save Lives, But Barriers Prevent Broad Access and Use, Says New Report
New study may help doctors and patients find a better balance between diabetes control and quality of life.
New German study finds that people taking this type of generic diabetes medication were less likely to develop diabetes.
A small clinical trial suggests that suramin can reverse some autism symptoms with one dose, based on the theory of cell danger response.
These days the subject of generic medications troubles many "anxious about our health government minds ".Generic drugs are unsafe, not helpful as brand names for your diseases , they are made in unautorised facilities ect . Is this the truth or is it just an attempt to favour some american drug manufacturers and pharmacies.
If you are one of those living with panic attack symptoms, you know it can almost take over your life. Living with the fear that you will have to suffer through another period of grief, pain, and discomfort is sometimes enough to bring on a panic attack.
Now there is an easy, at-home, cost-effective test to discover the sensitivities that may be causing a dog discomfort. A new consumer test will measure a dog's immune system against 150 food and environmental factors.
Apotex Corp., a generic pharmaceutical company headquartered in Florida, was charged with fixing the price of the generic drug pravastatin, the Department of Justice announced today. According to the one-count felony charge filed today in the U.S. District Court for the Eastern District of Pennsylvania in Philadelphia, Apotex and other generic drug companies agreed to increase and maintain the price of pravastatin, a commonly prescribed cholesterol medication that lowers the risk of heart disease and stroke. The conspiracy began in May 2013 and continued through December 2015.
Research Highlights: Adding cilostazol, an antiplatelet medication for leg pain, to other drugs tended to prevent re-blockage of carotid artery stents within two years. This is the first trial to show potential effectiveness of medical management for...
General medication disposal systems are provided. Aspects of the systems include devices having a sealable container dimensioned to accommodate a pharmaceutical composition; and an amount of an inactivating substance, e.g., granulated or pelletized activated carbon, present inside of the sealable container. Aspects of the invention further include methods of making and using the systems, as well as kits comprising the devices of the system.
Method and apparatus for disposal of used home medication which comprises an outer container being sealable and disposable containing an inner water-soluble packet/bag of gelling agent and coloring agent for stabilizing the used medication wherein the outer container comprises a foil-type container having a double sealing mechanism including a first zip lock sealing portion and a second self-sticking sealing portion to insure that the contents are safely sealed prior to disposal in a conventional home solid waste disposal unit.
When the present time of a clock circuit is a medication time recorded in advance in a SD card, a notice that the medication time has come is given by a voice output portion or the like. Presence/absence of a medicine package in each block of a medicine package case is sensed by a medicine package sensor. The time point and the presence/absence of the medicine package are recorded in the SD card. A notice corresponding to the presence/absence is output. At a time except for the medication time, taking-out of the case, opening/closing of the cover, taking-out and return of the medicine package are recorded in the SD card based on detection signals from the medicine package sensor, medicine package case sensor, and case cover opening/closing sensor. A notice corresponding to the sensed situation is output.
A system and method determine when fluid is not flowing properly from a secondary infusion source during a secondary infusion. The system includes an upstream pressure sensor and a processor programmed to receive signals from the sensor and analyze the signals to determine if secondary fluid flow is proper. The processor samples the output signals from the upstream pressure sensor and analyzes the sampled signals to determine if a pressure rise in the infusion line has occurred when the secondary infusion is initiated. If a pressure rise, indicating that fluid from the secondary container has begun flowing into the infusion line, has not been detected, the processor is programmed to provide a signal indicating that attention should be given to the infusion set up.
Medical devices, methods and kits are described. An exemplary medical device comprises a catheter that has a catheter wall and defines a catheter lumen, a bend, and a coil disposed distal to the bend. The catheter defines one or more apertures that extend through the catheter wall and are in communication with the catheter lumen.
In regional Victoria, palliative care patients are waiting hours and sometimes days for much-needed medications to help with pain and quality of life.
In celebration of the World Asthma Day, Open Airways launched the Medication Assistance Fund, which is aimed at providing financial assistance to anyone with asthma or COPD who is experiencing economic hardship during the Covid-19 pandemic so that they will be able to purchase their prescribed inhalers to control their asthma or COPD. A spokesperson said, […] |
This special issue focuses on Diabetes, Covid-19 and Inpatient Management.
Recorded April 14, 2020.
This podcast will cover:
Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.
Presented by:
Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health
Dr. Joshua Neumiller, Vice Chair & Allen I. White Distinguished Associate Professor of Pharmacotherapy at Washington State University
A new Rapid Recommendation from The BMJ suggests that for pregnant women, they may wish to avoid certain antiviral treatments for HIV. This recommendation differs from the WHO's, and to discuss why that is, and what makes that difference important, we're joined by Reed Siemieniuk, a physician and methodologist from McMaster University, and Alice...
More than ½ of patients leave hospital with changes to four or more of their long-term medications - but how appropriate are those changes? New research published on bmj.com looks at antihypertensive medication prescription changes to try and model that - and found that more than half of intensifications occurred in patients with previously well...
1) To examine trends in the use of diabetes medications and 2) to determine whether physicians individualize diabetes treatment as recommended by the American Diabetes Association (ADA).
We conducted a retrospective, cross-sectional analysis of 2003–2016 National Health and Nutrition Examination Survey (NHANES) data. We included people ≥18 years who had ever been told they had diabetes, had an HbA1C >6.4%, or had a fasting plasma glucose >125 mg/dL. Pregnant women, and those aged <20 years receiving only insulin were excluded. We assessed trends in use of ADA’s seven preferred classes from 2003–2004 to 2015–2016. We also examined use by hypoglycemia risk (sulfonylureas, insulin, and meglitinides), weight effect (sulfonylureas, thiazolidinediones [TZDs], insulin, and meglitinides), cardiovascular benefit (canagliflozin, empagliflozin, and liraglutide), and cost (brand-name medications and insulin analogs).
The final sample included 6,323 patients. The proportion taking any medication increased from 58% in 2003–2004 to 67% in 2015–2016 (P < 0.001). Use of metformin and insulin analogs increased, while use of sulfonylureas, TZDs, and human insulin decreased. Following the 2012 ADA recommendation, the choice of drug did not vary significantly by older age, weight, or presence of cardiovascular disease. Patients with low HbA1C, or HbA1C <6%, and age ≥65 years were less likely to receive hypoglycemia-inducing medications, while older patients with comorbidities were more likely. Insurance, but not income, was associated with the use of higher-cost medications.
Following ADA recommendations, the use of metformin increased, but physicians generally did not individualize treatment according to patients’ characteristics. Substantial opportunities exist to improve pharmacologic management of diabetes.
<span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">RT @imconair: Hrithik Roshan still under medication http://bit.ly/gFyC3O #IMCRadio.net</span></span>
Guidelines suggest young children with autism spectrum disorder (ASD) receive intensive nonpharmacologic interventions. Additionally, associated symptoms may be treated with psychotropic medications. Actual intervention use by young children has not been well characterized. Our aim in this study was to describe interventions received by young children (3–6 years old) with ASD. The association with sociodemographic factors was also explored.
Data were analyzed from the Autism Speaks Autism Treatment Network (AS-ATN), a research registry of children with ASD from 17 sites in the United States and Canada. AS-ATN participants receive a diagnostic evaluation and treatment recommendations. Parents report intervention use at follow-up visits. At follow-up, 805 participants had data available about therapies received, and 613 had data available about medications received.
The median total hours per week of therapy was 5.5 hours (interquartile range 2.0–15.0), and only 33.4% of participants were reported to be getting behaviorally based therapies. A univariate analysis and a multiple regression model predicting total therapy time showed that a diagnosis of ASD before enrollment in the AS-ATN was a significant predictor. Additionally, 16.3% of participants were on ≥1 psychotropic medication. A univariate analysis and a multiple logistic model predicting psychotropic medication use showed site region as a significant predictor.
Relatively few young children with ASD are receiving behavioral therapies or total therapy hours at the recommended intensity. There is regional variability in psychotropic medication use. Further research is needed to improve access to evidence-based treatments for young children with ASD.
Preventive asthma medications (PAMs) are a primary management strategy to control asthma morbidity. Little is known about changes over time in prevalence of PAM use among children and adolescents in the United States.
Our analysis demonstrates an increase in use of PAMs among children and adolescents with current asthma in the United States from 1988–1994 to 2005–2008, but racial and ethnic disparities in use of PAMs persist. (Read the full article)
Asthma is a common obstructive pulmonary disease experienced during pregnancy. Clinical guidelines recommend women with asthma maintain asthma medication use during pregnancy. Epidemiologic studies suggest an association between several types of defects and asthma or asthma medication use during pregnancy.
Data from a large, population-based, multicenter, case-control study was used. This provides the opportunity to study specific birth defects with minimal heterogeneity in case groups, as well as control for a variety of potential confounders. (Read the full article)
Tenfold medication error is a well-recognized risk of pharmacotherapy in pediatric practice but little evidence describes the circumstances of such errors.
This study identified 252 tenfold medication errors, 22 of which resulted in patient harm. We identified opioids and other high-risk medications to be associated with tenfold medication error and frequent, recurrent causes, mechanisms, and error enablers that suggest areas for future improvements. (Read the full article)
Nonadherence to antiretroviral therapy among children and youth with HIV is a frequent problem that can result in treatment failure and disease progression for this population. Children and adolescents face different barriers to adherence than adults infected with HIV.
Few studies have examined specific barriers to adherence as reported by children with perinatally acquired HIV and their caregivers. This report examines the agreement between child and caregiver perceptions of adherence barriers and the factors associated with these barriers. (Read the full article)
Asthma disparities exist, with Latino children of Caribbean descent at risk for poor disease control. Controller medications reduce symptoms; however, medication adherence remains suboptimal. Identifying what factors predict poor medication adherence in at-risk groups could identify important treatment targets.
This study is the first to assess objective rates of medication use among children with asthma in Puerto Rico. Findings suggest that interventions incorporating family resources and addressing parental beliefs about medications may be of benefit across cultural groups. (Read the full article)
Little is known about how communication during pediatric asthma visits is associated with child control medication adherence 1 month after the visit.
When providers asked for caregiver input into the asthma treatment plan during the visit, caregivers reported significantly higher child medication adherence to control medications 1 month later. (Read the full article)
College students with asthma tend to have worse health outcomes than their peers without asthma. Consistent use of controller medication could improve outcomes for these students, but a predictive model of appropriate use of controller medication is needed.
This study adds risk tolerance and time preference to previously studied factors of nonadherence with control medication. These preferences have substantial impacts on use of controller medication and the potential success of asthma education programs. (Read the full article)